These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9488199)

  • 21. Amlodipine Inhibits Vascular Cell Senescence and Protects Against Atherogenesis Through the Mechanism Independent of Calcium Channel Blockade.
    Kayamori H; Shimizu I; Yoshida Y; Hayashi Y; Suda M; Ikegami R; Katsuumi G; Wakasugi T; Minamino T
    Int Heart J; 2018 May; 59(3):607-613. PubMed ID: 29681573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of Ca(2+) channels involved in endothelin-1-induced mitogenic responses in vascular smooth muscle cells.
    Kawanabe Y; Okamoto Y; Hashimoto N; Masaki T
    Eur J Pharmacol; 2001 Jun; 422(1-3):15-21. PubMed ID: 11430908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium, calcium antagonists and experimental atherosclerosis.
    Paoletti R; Corsini A; Soma MR; Bernini F
    Blood Press Suppl; 1996; 4():12-5. PubMed ID: 8973776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amlodipine inhibits pro-inflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-gamma-stimulated cultured vascular smooth muscle cells.
    Chou TC; Yang SP; Pei D
    Jpn J Pharmacol; 2002 Jun; 89(2):157-63. PubMed ID: 12120758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ca(2+)-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells.
    Rödler S; Roth M; Nauck M; Tamm M; Block LH
    J Mol Cell Cardiol; 1995 Oct; 27(10):2295-302. PubMed ID: 8576944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic treatment of atherosclerosis: beyond lipid-lowering therapy.
    Marche P; Hérembert T; Zhu DL
    Int J Cardiol; 1997 Dec; 62 Suppl 2():S17-22. PubMed ID: 9488191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of anisodamine and dauricine on proliferation, DNA synthesis, and calcium influx in bovine anterior cerebral arterial smooth muscle cells in culture.
    Zeng GQ; Rui YC
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):308-11. PubMed ID: 1807078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
    Mori S; Ito H; Yamamoto K
    Tohoku J Exp Med; 1988 Apr; 154(4):329-33. PubMed ID: 3188001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Alterations of antiproliferative effects of serum obtained from patients with acute cerebral infarction treated with a radical scavenger, edaravone, with or without amlodipine using an in vitro cultured basilar artery smooth muscle cells].
    Yamaguchi T; Ida T; Kobayashi T; Hiraga M; Oishi K; Uchida MK; Echizen H
    Yakugaku Zasshi; 2004 Jan; 124(1):25-9. PubMed ID: 14768352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells.
    Eickelberg O; Roth M; Mussmann R; Rüdiger JJ; Tamm M; Perruchoud AP; Block LH
    Circulation; 1999 May; 99(17):2276-82. PubMed ID: 10226093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.
    Ohlstein EH; Douglas SA; Sung CP; Yue TL; Louden C; Arleth A; Poste G; Ruffolo RR; Feuerstein GZ
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6189-93. PubMed ID: 8327499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of manidipine hydrochloride on proliferation and glycosaminoglycan synthesis of cultured vascular smooth muscle cells.
    Morimoto S; Nabata T; Fukuo K; Yasuda O; Inoue T; Momose N; Koh E; Kitano S; Tamatani M; Ogihara T
    Blood Press Suppl; 1992; 3():27-9. PubMed ID: 1343285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of vascular smooth muscle cell proliferation by the calcium antagonist clentiazem: role of protein kinase C.
    Alam R; Kataoka S; Alam S; Yatsu F
    Atherosclerosis; 1996 Oct; 126(2):207-19. PubMed ID: 8902146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The smooth muscle cell membrane during atherogenesis: a potential target for amlodipine in atheroprotection.
    Tulenko TN; Sumner AE; Chen M; Huang Y; Laury-Kleintop L; Ferdinand FD
    Am Heart J; 2001 Feb; 141(2 Suppl):S1-11. PubMed ID: 11174352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prominent inhibitory effects of tranilast on migration and proliferation of and collagen synthesis by vascular smooth muscle cells.
    Tanaka K; Honda M; Kuramochi T; Morioka S
    Atherosclerosis; 1994 Jun; 107(2):179-85. PubMed ID: 7526874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive effect of calcium channel blockers is parallel with carbonic anhydrase I inhibition.
    Puscas I; Gilau L; Coltau M; Pasca R; Domuta G; Baican M; Hecht A
    Clin Pharmacol Ther; 2000 Oct; 68(4):443-9. PubMed ID: 11061585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular processes in atherogenesis: potential targets of Ca2+ channel blockers.
    Schmitz G; Hankowitz J; Kovacs EM
    Atherosclerosis; 1991 Jun; 88(2-3):109-32. PubMed ID: 1654052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-3 stimulates migration and proliferation of vascular smooth muscle cells: a potential role in atherogenesis.
    Brizzi MF; Formato L; Dentelli P; Rosso A; Pavan M; Garbarino G; Pegoraro M; Camussi G; Pegoraro L
    Circulation; 2001 Jan; 103(4):549-54. PubMed ID: 11157721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diltiazem, a calcium antagonist, inhibits matrix metalloproteinase-1 (tissue collagenase) production and collagenolytic activity in human vascular smooth muscle cells.
    Wada Y; Kato S; Okamoto K; Izumaru S; Aoyagi S; Morimatsu M
    Int J Mol Med; 2001 Nov; 8(5):561-6. PubMed ID: 11605028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.